V
50
4
RSG
73
3
GWW
60
7
VIX
32
-11
IR
61
3
SYF
69
4
VFC
39
4
ED
45
-4
AMZN
55
5
IPG
45
-4
OXY
48
2
WEC
73
-5
DG
33
-3
GE
67
2
EXR
48
8
NRG
69
17
KEY
48
2
PNR
51
4
LOW
39
2
WMT
58
3
V
50
4
RSG
73
3
GWW
60
7
VIX
32
-11
IR
61
3
SYF
69
4
VFC
39
4
ED
45
-4
AMZN
55
5
IPG
45
-4
OXY
48
2
WEC
73
-5
DG
33
-3
GE
67
2
EXR
48
8
NRG
69
17
KEY
48
2
PNR
51
4
LOW
39
2
WMT
58
3
Financhill
Back

INmune Bio Vs. Novartis AG Industry Stock Comparison

Sell
45

INMB
INmune Bio

Last Price:
$8.86
Seasonality Move:
36.2%
Buy
71

NVSEF
Novartis AG

Last Price:
$116.60
Seasonality Move:
6.56%
Sell
45
INmune Bio (INMB) is a Sell

Is INmune Bio a Buy, Sell or Hold?

  • The current INmune Bio [INMB] share price is $8.30. The Score for INMB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • INMB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Novartis AG (NVSEF) is a Buy

Is Novartis AG a Buy, Sell or Hold?

  • The current Novartis AG [NVSEF] share price is $116.60. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

INMB Stock Price Chart

What is INmune Bio's stock price today?

  • The INmune Bio share price today is $8.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INMB is experiencing slight selling pressure.

NVSEF Stock Price Chart

What is Novartis AG's stock price today?

  • The Novartis AG share price today is $116.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.

INMB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 52.2 Buy
Chaikin Money Flow: -84648 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.71 - 8.85) Buy
Bollinger Bands (100): (4.95 - 8.39) Buy

NVSEF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.84 Buy
Relative Strength Index (14 RSI): 61.26 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (107.1 - 113.78) Buy
Bollinger Bands (100): (98.55 - 109.41) Buy

INMB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.97 Buy
20-day SMA: 8.03 Buy
50-day SMA: 8.11 Buy
200-day SMA: 6.87 Buy
8-day EMA: 8.09 Buy
20-day EMA: 8.14 Buy
50-day EMA: 7.81 Buy
200-day EMA: 7.38 Buy

NVSEF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 110.96 Buy
20-day SMA: 111.23 Buy
50-day SMA: 106.01 Buy
200-day SMA: 106.77 Buy
8-day EMA: 112.31 Buy
20-day EMA: 110.66 Buy
50-day EMA: 107.55 Buy
200-day EMA: 104.74 Buy

INmune Bio Earnings Growth & INMB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.29 per share.

Novartis AG Earnings Growth & NVSEF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

INmune Bio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novartis AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):